Skip to content

Abivax

  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Overview
    • Patients
    • ABX464 for UC
    • ABX464 for Crohn’s
    • ABX464 for RA
    • ABX464 for COVID-19
    • ABX464 for HIV
    • ABX196 for HCC
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Overview
    • Share Price
    • Investor Documents
    • Annual General Meeting
  • Contact Us
Search
  • EN
  • FR
  • DE

Investors

Investor Documents

  • Half-Year Report For Liquidity Contract - June 30, 2020

    July 21, 2020
  • Number of Shares and Vote Rights - June 2020

    July 21, 2020
  • Number of Shares and Vote Rights - May 2020

    June 30, 2020
  • 2020 Universal Registration Document

    May 25, 2020
  • Number of Shares and Vote Rights - April 2020

    May 19, 2020
  • Number of Shares and Vote Rights - March 2020

    April 15, 2020
  • Number of Shares and Vote Rights - February 2020

    March 19, 2020
  • Number of Shares and Vote Rights - January 2020

    February 19, 2020
  • 1
  • 2
  • 3
  • 4
  • …
  • 12

Investor Contact

Chris Maggos LifeSci Advisors Chris@lifesciadvisors.com +41 79 367 6254
© 2021 All rights reserved by ABIVAX | Website created by DIGITAL VALLEE Privacy and Terms of Use
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • ABX464 for UC
    • ABX464 for HIV
    • ABX196 for HCC
    • ABX544 for Ebola Virus
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Share Profile
    • Share Price
    • Investor Documents
    • Analysts
    • Annual General Meeting
    • UEG Week 2019
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Google+